Quest PharmaTech Inc. (QPTFF)の価格はいくらですか

Quest PharmaTech Inc. (QPTFF)の価格は$0.02です

Quest PharmaTech Inc. (QPTFF)の時価総額は何ですか

Quest PharmaTech Inc. (QPTFF)の時価総額は$3.38Mです

Quest PharmaTech Inc.（QPTFF）の株価履歴

Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer treatment applications. The company's offerings further encompass Oregovomab, an anti-CA-125 antibody that has successfully completed Phase II clinical trials for the management of ovarian cancer. Beyond these specific agents, Quest PharmaTech is actively involved in the development, manufacturing, and commercialization of new immunotherapy products aimed at combating pancreatic cancer. The organization also diversifies its portfolio by utilizing proprietary transdermal delivery technologies to formulate products for dermatological conditions and wound healing. Additionally, it develops specialized skin-penetrating active molecules for use in both cosmetic and pharmaceutical goods. Rounding out its innovative efforts, Quest PharmaTech designs intricate combinatorial immunotherapies for cancer, employing monoclonal antibodies belonging to both immunoglobulin G and E classes.

年	パフォーマンス
2026 (TTM)	88.06%
2025	0.00%
2024	-66.75%
2023	-47.51%
2022	27.00%
2021	-60.30%
2020	82.09%
2019	-12.35%
2018	0.00%

年

パフォーマンス

2026 (TTM)

88.06%

2025

0.00%

2024

-66.75%

2023

-47.51%

2022

27.00%

2021

-60.30%

2020

82.09%

2019

-12.35%

2018

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$505.24	28.63%	US
Argenx SE ARGX.US	$846.09	29.41%	NL
Lonza Group AG LONN.SW	$731.69	6.47%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$251.82	11.75%	BE

企業

株価

変化率 1年%

国